Brain O
Circuitry O
Associated O
with O
the O
Development O
of O
Substance O
Use O
in O
Bipolar O
Disorder O
and O
Preliminary O
Evidence O
for O
Sexual O
Dimorphism O
in O
Adolescents O
Substance O
use O
disorders O
( O
SUDs O
) O
and O
mood O
disorders O
are O
highly O
comorbid O
and O
confer O
a O
high O
risk O
for O
adverse O
outcomes O
. O

However O
, O
data O
are O
limited O
on O
the O
neurodevelopmental O
basis O
of O
this O
comorbidity O
. O

Substance O
use O
initiation O
typically O
occurs O
during O
adolescence O
and O
sex-specific O
developmental O
mechanisms O
are O
implicated O
. O

In O
this O
preliminary O
study O
we O
review O
the O
literature O
and O
investigate O
regional O
gray O
matter O
volume O
( O
GMV O
) O
associated O
with O
subsequent O
substance O
use O
problems O
in O
adolescents O
with O
bipolar O
disorder O
( O
BD O
) O
and O
explore O
these O
associations O
for O
females O
and O
males O
. O

Thirty O
DSM-IV O
diagnosed O
BD O
adolescents O
with O
minimal O
alcohol/substance O
exposure O
completed O
baseline O
structural O
magnetic O
resonance O
imaging O
scans O
. O

At O
follow-up O
( O
on O
average O
6 O
years O
post-baseline O
) O
, O
subjects O
were O
administered O
the O
CRAFFT O
interview O
and O
categorized O
into O
those O
scoring O
at O
high O
( O
> O
2 O
: O
CRAFFTHIGH O
) O
versus O
low O
( O
< O
2 O
: O
CRAFFTLOW O
) O
risk O
for O
alcohol/substance O
problems O
. O

Lower O
GMV O
in O
prefrontal O
, O
insular O
, O
and O
temporopolar O
cortices O
were O
observed O
at O
baseline O
among O
adolescents O
with O
BD O
reporting O
subsequent O
alcohol O
and O
cannabis O
use O
compared O
to O
adolescents O
with O
BD O
who O
did O
not O
( O
p O
< O
0.005 O
, O
clusters O
> O
20 O
voxels O
) O
. O

Lower O
dorsolateral O
prefrontal O
GMV O
was O
associated O
with O
future O
substance O
use O
in O
both O
females O
and O
males O
. O

In O
females O
, O
lower O
orbitofrontal O
and O
insula O
GMV O
was O
associated O
with O
future O
substance O
use O
; O
while O
in O
males O
, O
lower O
rostral O
prefrontal O
GMV O
was O
associated O
with O
future O
use O
. O

Lower O
orbitofrontal O
, O
insular O
and O
temporopolar O
GMV O
was O
observed O
in O
those O
who O
transitioned O
to O
smoking O
tobacco O
. O

Findings O
indicate O
GMV O
development O
is O
associated O
with O
risk O
for O
future O
substance O
use O
problems O
in O
adolescents O
with O
BD O
, O
with O
results O
implicating O
GMV O
development O
in O
regions O
subserving O
emotional O
regulation O
in O
females O
and O
regions O
subserving O
executive O
processes O
and O
attention O
in O
males O
. O

Graphical O
abstract O
This O
study O
demonstrates O
regional O
gray O
matter O
volume O
decreases O
that O
may O
distinguish O
adolescents O
with O
Bipolar O
Disorder O
and O
elevated O
risk O
for O
future O
substance O
use O
problems O
. O

Preliminary O
findings O
suggest O
in O
females O
, O
regions O
associated O
with O
internalizing O
behavior O
and O
affective O
processing O
are O
related O
to O
risk O
; O
in O
males O
, O
regions O
associated O
with O
attention O
and O
other O
executive O
processes O
. O

MATERIALS O
AND O
METHODS O
Participants O
Subjects O
who O
were O
assessed O
and O
scanned O
in O
a O
cross-sectional O
study O
and O
consented O
to O
being O
re-contacted O
were O
re-contacted O
and O
recruited O
if O
they O
met O
inclusion O
and O
did O
not O
meet O
exclusion O
criteria O
. O

Participants O
included O
30 O
adolescents/young O
adults O
diagnosed O
with O
BD O
[ O
mean O
age O
at O
baseline O
+ O
standard O
deviation O
( O
SD O
) O
= O
16+2 O
years O
; O
29 O
( O
97 O
% O
) O
BDI O
, O
1 O
( O
3 O
% O
) O
BDII O
; O
50 O
% O
female O
; O
mean O
age O
at O
follow-up= O
22+3 O
years O
] O
( O
see O
Table O
1 O
for O
participant O
characterization O
) O
. O

The O
presence/absence O
of O
psychiatric O
diagnoses O
and O
mood O
state O
at O
time O
of O
neuroimaging O
were O
confirmed O
with O
the O
Structured O
Clinical O
Interview O
for O
DSM-IV O
Diagnosis O
for O
participants O
≥18 O
years O
and O
the O
Kiddie-Schedule O
for O
Affective O
Disorders O
and O
Schizophrenia O
for O
participants O
< O
18 O
years O
. O

At O
baseline O
assessment O
, O
all O
participants O
completed O
sMRI O
. O

At O
follow-up O
assessment O
, O
on O
average O
6+2 O
years O
after O
baseline O
assessment O
, O
subjects O
completed O
the O
CRAFFT O
interview O
to O
assess O
alcohol O
and O
substance O
use O
problems O
since O
baseline O
assessment O
. O

As O
the O
aim O
of O
this O
study O
was O
to O
examine O
baseline O
GMV O
as O
a O
predictor O
of O
future O
alcohol O
and O
substance O
use O
problems O
, O
subjects O
were O
excluded O
if O
at O
baseline O
they O
self-reported O
more O
than O
minimal O
alcohol O
and/or O
cannabis O
exposure O
or O
ever O
having O
used O
cocaine O
, O
opioids O
, O
phencyclidine O
, O
hallucinogens O
, O
or O
solvents/inhalants O
. O

Sixty-three O
percent O
of O
subjects O
( O
11 O
males O
, O
8 O
females O
) O
reported O
never O
trying O
alcohol O
or O
any O
other O
illicit O
substances O
or O
having O
tried O
a O
sip O
of O
alcohol O
once O
at O
a O
family O
gathering O
. O

Remaining O
subjects O
reported O
having O
tried O
alcohol O
or O
cannabis O
once O
or O
on O
a O
few O
occasions O
with O
peers O
. O

Subjects O
were O
not O
excluded O
for O
tobacco O
use O
. O

At O
baseline O
and O
follow-up O
assessment O
, O
tobacco O
use O
was O
assessed O
as O
smoking O
using O
the O
Fagerstrom O
Test O
for O
Nicotine O
Dependence O
( O
FTND O
) O
. O

At O
baseline O
, O
two O
subjects O
( O
7 O
% O
) O
reported O
current O
smoking O
and O
one O
subject O
( O
3 O
% O
) O
reported O
past O
history O
of O
, O
but O
not O
current O
, O
smoking O
. O

Transition O
to O
smoking O
was O
studied O
in O
remaining O
subjects O
. O

In O
addition O
to O
the O
3 O
subjects O
with O
a O
history O
of O
smoking O
tobacco O
at O
baseline O
, O
11 O
individuals O
( O
41 O
% O
; O
7 O
females O
) O
with O
no O
tobacco O
use O
at O
baseline O
reported O
history O
of O
smoking O
at O
follow-up O
( O
8 O
were O
currently O
smoking O
at O
follow-up O
assessment O
; O
4 O
female O
current O
smokers O
at O
follow-up O
) O
. O

Sixteen O
individuals O
( O
53 O
% O
; O
6 O
females O
) O
reported O
no O
history O
of O
smoking O
tobacco O
at O
either O
time O
point O
. O

On O
the O
neuroimaging O
day O
, O
urine O
toxicology O
screens O
for O
substances O
of O
abuse O
( O
cannabis O
, O
cocaine O
, O
amphetamine O
, O
methamphetamine O
, O
methadone O
, O
opiates O
, O
phencyclidine O
, O
barbiturates O
, O
and O
benzodiazepines O
) O
were O
negative O
for O
all O
subjects O
. O

Exclusion O
criteria O
included O
history O
of O
neurological O
illness O
, O
including O
head O
trauma O
with O
loss O
of O
consciousness O
for O
≥5min O
, O
or O
major O
medical O
illness O
. O

Subjects O
were O
not O
excluded O
for O
comorbidities O
or O
family O
history O
of O
psychiatric O
disorders O
as O
there O
are O
high O
rates O
of O
these O
in O
individuals O
with O
BD O
and O
excluding O
decreases O
generalizability O
. O

After O
complete O
description O
of O
the O
study O
, O
written O
informed O
consent O
was O
obtained O
from O
subjects O
≥18 O
years O
, O
and O
assent O
and O
parent/guardian O
permission O
from O
subjects O
< O
18 O
, O
in O
accordance O
with O
the O
Yale O
School O
of O
Medicine O
human O
investigation O
committee O
. O

MRI O
Acquisition O
and O
Processing O
High-resolution O
sMRI O
data O
were O
acquired O
for O
each O
subject O
with O
a O
3-Tesla O
Siemens O
Trio O
MR O
scanner O
( O
Siemens O
, O
Erlangen O
, O
Germany O
) O
. O

The O
sMRI O
sagittal O
images O
were O
acquired O
with O
a O
three-dimensional O
magnetization O
prepared O
rapid O
acquisition O
gradient O
echo O
( O
MPRAGE O
) O
T1-weighted O
sequence O
with O
parameters O
: O
repetition O
time O
( O
TR O
) O
=1500ms O
, O
echo O
time O
( O
TE O
) O
=2.83ms O
, O
matrix O
256 O
× O
256 O
, O
field O
of O
view O
( O
FOV O
) O
=256mm O
x O
256mm2 O
, O
and O
160 O
one-mm O
slices O
without O
gap O
and O
two O
averages O
. O

Images O
were O
processed O
with O
the O
DARTEL O
toolbox O
within O
Statistical O
and O
Parametric O
Mapping O
12 O
( O
SPM12 O
) O
( O
http O
: O
//www.fil.ion.ucl.ac.uk/spm O
) O
. O

The O
SPM O
segmentation O
function O
and O
SPM O
tissue O
probability O
maps O
for O
gray O
matter O
, O
white O
matter O
and O
cerebral O
spinal O
fluid O
were O
implemented O
for O
bias O
correction O
and O
segmentation O
and O
used O
to O
create O
DARTEL O
templates O
using O
the O
“ O
Run O
Dartel O
( O
create O
Templates O
) O
” O
command O
under O
DARTEL O
tools O
. O

Data O
were O
normalized O
to O
Montreal O
Neurological O
Institute O
( O
MNI O
) O
space O
and O
smoothed O
with O
an O
8mm O
full-width-at-half-maximum O
( O
FWHM O
) O
isotropic O
kernel O
. O

Alcohol O
and O
Substance O
Use O
Subjects O
were O
administered O
the O
CRAFFT O
interview O
, O
which O
consists O
of O
6 O
yes/no O
questions O
inquiring O
about O
risk O
indicators O
or O
problems O
experienced O
from O
alcohol O
or O
drug O
use O
. O

CRAFFT O
is O
an O
acronym O
with O
each O
letter O
representing O
one O
of O
6 O
items O
. O

C O
relates O
to O
history O
of O
driving O
or O
riding O
in O
a O
Car O
driven O
by O
someone O
who O
had O
been O
using O
alcohol/drugs O
, O
R O
if O
used O
alcohol/drugs O
to O
Relax O
, O
A O
if O
used O
alcohol/drugs O
while O
Alone O
, O
F O
if O
Forgotten O
things O
one O
did O
while O
using O
alcohol/drugs O
, O
F O
whether O
told O
by O
Family/Friends O
to O
cut O
down O
on O
alcohol/drug O
use O
, O
and O
T O
whether O
gotten O
into O
Trouble O
while O
using O
alcohol/drugs O
. O

The O
questions O
are O
equally O
weighted O
( O
one O
point O
for O
each O
yes O
answer O
) O
. O

The O
CRAFFT O
has O
substantial O
empirical O
support O
as O
a O
substance O
use O
screening O
instrument O
for O
adolescents O
in O
multiple O
settings O
, O
including O
outpatient O
general O
medical O
and O
inpatient O
psychiatric O
settings O
. O

A O
score O
of O
≥2 O
has O
been O
used O
as O
the O
threshold O
optimal O
for O
identifying O
alcohol/substance O
problems O
. O

At O
follow-up O
, O
19 O
( O
63 O
% O
) O
participants O
had O
a O
CRAFFT O
score O
of O
≥2 O
( O
CRAFFTmean+SD= O
2.3+2.1 O
; O
scores O
ranged O
from O
0–6 O
and O
showed O
a O
normal O
distribution O
in O
both O
males O
and O
females O
) O
. O

Additional O
Assessments O
Participants O
were O
assessed O
with O
the O
Young O
Mania O
Rating O
Scale O
and O
the O
2-subtest O
version O
( O
Matrix O
Reasoning O
and O
Vocabulary O
) O
of O
the O
Weschler O
Abbreviated O
Scales O
of O
Intelligence O
. O

Additionally O
, O
at O
baseline O
assessment O
, O
27 O
participants O
[ O
14 O
female O
( O
51 O
% O
) O
] O
completed O
the O
Child O
Depression O
Rating O
Scale O
( O
CDRS O
) O
and O
25 O
participants O
[ O
12 O
female O
( O
48 O
% O
) O
] O
the O
Barratt O
Impulsiveness O
Scale O
( O
BIS O
) O
-11 O
or O
BIS-11a O
. O

The O
BIS O
is O
a O
self-reported O
measure O
of O
trait O
impulsivity O
. O

The O
total O
BIS O
score O
is O
the O
sum O
of O
three O
subscale O
scores O
: O
non-planning O
impulsivity O
, O
cognitive-attentional O
impulsivity O
, O
and O
motor O
impulsivity O
. O

BIS-11a O
scores O
were O
prorated O
to O
BIS-11 O
scores O
as O
previously O
described O
. O

Statistical O
Analyses O
Demographic O
and O
Clinical O
Feature O
Analysis O
Subjects O
were O
categorized O
into O
those O
scoring O
at O
high O
( O
> O
2 O
: O
CRAFFTHIGH O
) O
versus O
low O
( O
< O
2 O
: O
CRAFFTLOW O
) O
risk O
for O
alcohol O
and O
substance O
use O
problems O
. O

Independent O
t-tests O
were O
performed O
to O
assess O
group O
differences O
in O
age O
at O
baseline O
scans O
, O
age O
at O
follow-up O
, O
interval O
between O
baseline O
scan O
and O
follow-up O
, O
and O
baseline O
IQ O
, O
years O
of O
education O
, O
Young O
Mania O
Rating O
Scale O
, O
CDRS O
and O
BIS O
( O
total O
and O
subscale O
) O
scores O
. O

Chi-square O
( O
or O
Fisher O
’ O
s O
exact O
) O
tests O
were O
used O
to O
examine O
whether O
clinical O
factors O
differed O
by O
CRAFFT O
group O
at O
baseline O
( O
see O
Table O
2 O
and O
Table O
3 O
) O
. O

These O
included O
mood O
state O
( O
euthymic O
, O
depressed O
, O
elevated O
) O
, O
history O
( O
yes/no O
) O
of O
hospitalization O
, O
rapid O
cycling O
, O
psychosis O
, O
suicide O
attempt O
, O
smoking O
tobacco O
, O
comorbid O
diagnosis O
( O
yes/no O
) O
of O
simple/specific O
phobia O
, O
ADHD O
, O
ODD O
, O
CD O
, O
or O
separation O
anxiety O
, O
and O
medication O
subclasses O
( O
on/off O
) O
. O

Analyses O
were O
repeated O
stratified O
by O
sex O
. O

Additionally O
, O
a O
Chi-square O
test O
was O
used O
to O
assess O
if O
the O
number O
of O
individuals O
transitioning O
to O
smoking O
tobacco O
between O
baseline O
and O
follow-up O
assessment O
differed O
by O
CRAFFT O
group O
( O
excluding O
3 O
individuals O
with O
baseline O
history O
of O
tobacco O
use O
) O
. O

A O
Fisher O
’ O
s O
exact O
test O
was O
used O
to O
assess O
whether O
CRAFFTHIGH O
males O
and O
females O
differed O
in O
the O
number O
of O
individuals O
who O
transitioned O
to O
smoking O
tobacco O
between O
baseline O
and O
follow-up O
assessment O
. O

Results O
were O
considered O
significant O
at O
p O
< O
0.05 O
. O

SPM O
Voxel-Based O
Analysis O
A O
two-sample O
t-test O
was O
conducted O
in O
SPM12 O
to O
assess O
CRAFFTHIGH O
versus O
CRAFFTLOW O
group O
differences O
in O
baseline O
GMV O
, O
including O
data O
from O
all O
subjects O
. O

For O
hypothesized O
regions O
, O
PFC O
, O
insular O
and O
temporopolar O
cortices O
and O
amygdala O
, O
results O
were O
considered O
significant O
at O
p O
< O
0.005 O
( O
uncorrected O
) O
and O
clusters O
> O
20 O
voxels O
. O

This O
threshold O
was O
chosen O
to O
balance O
for O
type O
I O
and O
type O
II O
errors O
in O
preliminary O
studies O
. O

For O
remaining O
brain O
regions O
, O
findings O
were O
considered O
as O
significant O
with O
p O
< O
0.05 O
Family-Wise O
Error O
( O
FWE O
) O
-corrected O
and O
a O
threshold O
of O
10 O
voxels O
for O
multiple O
comparisons O
. O

Mean O
GMV O
, O
extracted O
from O
clusters O
showing O
significant O
differences O
between O
CRAFFT O
groups O
, O
were O
calculated O
. O

Post O
hoc O
analysis O
was O
performed O
to O
assess O
effect O
of O
CRAFFT O
group O
when O
covarying O
age O
or O
IQ O
at O
baseline O
, O
with O
GMV O
from O
extracted O
clusters O
as O
the O
dependent O
variables O
. O

To O
further O
confirm O
regional O
GMV O
association O
with O
CRAFFT O
outcome O
, O
the O
relationship O
between O
mean O
GMV O
in O
significant O
clusters O
with O
total O
CRAFFT O
score O
was O
assessed O
with O
Pearson O
correlations O
across O
all O
subjects O
. O

Correlations O
were O
repeated O
stratified O
by O
sex O
to O
explore O
sex-related O
patterns O
in O
volumetric O
features O
associated O
with O
the O
development O
of O
substance O
use O
problems O
. O

Correlation O
analyses O
were O
also O
performed O
across O
all O
subjects O
, O
and O
stratified O
by O
sex O
, O
to O
assess O
relationship O
between O
GMV O
and O
baseline O
CDRS O
or O
BIS O
( O
total O
and O
subscale O
) O
scores O
. O

Based O
on O
our O
a O
priori O
hypotheses O
, O
GMV O
from O
clusters O
within O
rostral O
PFC O
( O
rPFC O
) O
and O
dorsolateral O
PFC O
( O
dlPFC O
) O
showing O
a O
significant O
difference O
between O
CRAFFT O
groups O
were O
assessed O
for O
relationship O
with O
BIS O
( O
total O
and O
subscales O
) O
scores O
; O
GMV O
from O
clusters O
within O
orbitofrontal O
cortex O
( O
OFC O
) O
and O
insular O
and O
temporopolar O
cortices O
were O
assessed O
for O
relationship O
with O
baseline O
CDRS O
scores O
. O

Post O
hoc O
analyses O
above O
were O
repeated O
after O
removing O
3 O
subjects O
with O
a O
history O
of O
tobacco O
use O
at O
baseline O
. O

A O
t-test O
was O
used O
to O
explore O
differences O
in O
extracted O
GMV O
, O
from O
significant O
regions O
identified O
in O
the O
CRAFFT O
group O
analysis O
above O
, O
between O
individuals O
who O
never O
smoked O
tobacco O
at O
either O
assessment O
( O
N=16 O
) O
and O
those O
who O
transitioned O
to O
smoking O
tobacco O
between O
baseline O
and O
follow-up O
assessment O
( O
N=11 O
) O
. O

Regional O
GMV O
identified O
as O
being O
associated O
with O
transitioning O
to O
smoking O
tobacco O
were O
explored O
across O
all O
subjects O
who O
transitioned O
and O
were O
currently O
smoking O
tobacco O
at O
follow-up O
using O
Pearson O
correlations O
to O
determine O
relationships O
with O
total O
FTND O
scores O
. O

We O
performed O
t-tests O
to O
explore O
associations O
between O
mean O
GMV O
in O
significant O
clusters O
with O
clinical O
and O
medication O
subclass O
factors O
present O
and O
absent O
at O
baseline O
in O
N O
> O
5 O
subjects O
, O
including O
mood O
state O
( O
euthymic O
versus O
elevated O
) O
, O
history O
( O
yes/no O
) O
of O
hospitalizations O
, O
rapid O
cycling O
, O
lifetime O
psychosis O
, O
and O
if O
taking O
( O
off/on O
) O
an O
antipsychotic O
, O
anticonvulsant O
, O
stimulant O
, O
lithium O
, O
antidepressant O
, O
or O
benzodiazepine O
. O

Analyses O
were O
repeated O
stratified O
by O
sex O
for O
clinical O
factors O
present O
or O
absent O
at O
baseline O
in O
N O
> O
5 O
female O
or O
male O
subjects O
, O
including O
history O
( O
yes/no O
) O
at O
baseline O
of O
rapid O
cycling O
, O
lifetime O
psychosis O
, O
and O
if O
taking O
( O
off/on O
) O
an O
antipsychotic O
at O
baseline O
. O

In O
females O
, O
we O
assessed O
effects O
of O
taking O
an O
anticonvulsant O
and O
differences O
between O
subjects O
transitioning O
to O
smoking O
tobacco O
between O
baseline O
and O
follow-up O
assessments O
( O
N=7 O
females O
) O
, O
compared O
to O
those O
reporting O
no O
history O
of O
smoking O
at O
either O
assessment O
( O
N=6 O
females O
) O
. O

In O
males O
, O
we O
assessed O
effects O
of O
comorbid O
ADHD O
and O
taking O
a O
stimulant O
or O
lithium O
at O
baseline O
assessment O
, O
but O
did O
not O
assess O
for O
smoking O
conversion O
as O
only O
4 O
males O
converted O
. O

These O
post O
hoc O
analyses O
were O
considered O
significant O
at O
p O
< O
0.05 O
. O

All O
significant O
results O
are O
reported O
below O
. O

